InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (1 ops.)
Explore the complete record of transactions filed by A2A Pharmaceuticals, Inc.. Officer active across 1 companies, notably Biomea Fusion, Inc.. Aggregated, 3 filings have been logged. Total volume traded: €1m. The latest transaction was disclosed on 24 June 2022 — Cession. Regulator: SEC (Form 4). The full history is openly available.
Declarations3 total
€387,42734,658 shares@ €11.17860.40% mcap37.5% of flow
Common Stock
SEC:0001856641-22-000001:0·
€322,79834,658 shares@ €9.3138100.0% of flow
Common Stock
SEC:0000899243-21-036769·
Ideal exit: 14 Jun 2022 (T+270)
€322,79834,658 shares@ €9.31380.33% mcap31.2% of flow
Common Stock
SEC:0000899243-21-036769:0·
Ideal exit: 14 Jun 2022 (T+270)
3 of 3 declarations
